Society of Pain and Palliative Care Pharmacists White Paper on the Role of Opioid Stewardship Pharmacists.

IF 0.9 Q3 ANESTHESIOLOGY
Sandra DiScala, Tanya J Uritsky, Michelle E Brown, Stephanie M Abel, Nicole T Humbert, Dharma Naidu
{"title":"Society of Pain and Palliative Care Pharmacists White Paper on the Role of Opioid Stewardship Pharmacists.","authors":"Sandra DiScala,&nbsp;Tanya J Uritsky,&nbsp;Michelle E Brown,&nbsp;Stephanie M Abel,&nbsp;Nicole T Humbert,&nbsp;Dharma Naidu","doi":"10.1080/15360288.2022.2149670","DOIUrl":null,"url":null,"abstract":"<p><p>Opioid stewardship is one essential function of pain and palliative care pharmacists and a critical need in the United States. In recent years, this country has been plagued by two public health emergencies: an opioid crisis and the COVID-19 pandemic, which has exacerbated the opioid epidemic through its economic and psychosocial toll. To develop an opioid stewardship program, a systematic approach is needed. This will be detailed in part here by the Opioid Stewardship Taskforce of the Society of Pain and Palliative Care Pharmacists (SPPCP), focusing on the role of the pharmacist. Many pain and palliative care pharmacists have made significant contributions to the development and daily operation of such programs while also completing other competing clinical tasks, including direct patient care. To ensure dedicated time and attention to critical opioid stewardship efforts, SPPCP recommends and endorses opioid stewardship models employing a full time, opioid stewardship pharmacist in both the inpatient and outpatient setting. Early research suggests that opioid stewardship pharmacists are pivotal to improving opioid metrics and pain care outcomes. However, further research and development in this area of practice is needed and encouraged.</p>","PeriodicalId":16645,"journal":{"name":"Journal of Pain & Palliative Care Pharmacotherapy","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pain & Palliative Care Pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15360288.2022.2149670","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Opioid stewardship is one essential function of pain and palliative care pharmacists and a critical need in the United States. In recent years, this country has been plagued by two public health emergencies: an opioid crisis and the COVID-19 pandemic, which has exacerbated the opioid epidemic through its economic and psychosocial toll. To develop an opioid stewardship program, a systematic approach is needed. This will be detailed in part here by the Opioid Stewardship Taskforce of the Society of Pain and Palliative Care Pharmacists (SPPCP), focusing on the role of the pharmacist. Many pain and palliative care pharmacists have made significant contributions to the development and daily operation of such programs while also completing other competing clinical tasks, including direct patient care. To ensure dedicated time and attention to critical opioid stewardship efforts, SPPCP recommends and endorses opioid stewardship models employing a full time, opioid stewardship pharmacist in both the inpatient and outpatient setting. Early research suggests that opioid stewardship pharmacists are pivotal to improving opioid metrics and pain care outcomes. However, further research and development in this area of practice is needed and encouraged.

疼痛与姑息治疗药剂师协会阿片类药物管理药剂师的角色白皮书。
阿片类药物管理是疼痛和姑息治疗药剂师的一项基本功能,也是美国的一项关键需求。近年来,该国一直受到两起突发公共卫生事件的困扰:阿片类药物危机和COVID-19大流行,后者通过其经济和社会心理代价加剧了阿片类药物的流行。为了制定阿片类药物管理计划,需要一种系统的方法。这将由疼痛和姑息治疗药剂师协会(SPPCP)的阿片类药物管理工作组在这里部分详细说明,重点是药剂师的作用。许多疼痛和姑息治疗药剂师在完成其他竞争性临床任务(包括直接患者护理)的同时,对这些项目的发展和日常运作做出了重大贡献。为了确保对关键的阿片类药物管理工作投入时间和精力,SPPCP建议并支持在住院和门诊环境中雇用全职阿片类药物管理药剂师的阿片类药物管理模式。早期研究表明,阿片类药物管理药剂师对改善阿片类药物指标和疼痛护理结果至关重要。然而,需要并鼓励在这一实践领域进行进一步的研究和开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
9.10%
发文量
40
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信